Condition: Asthma
Intervention: Other: Clinical asthma remission
Sponsor: Mahidol University
Recruiting – verified August 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Other: Clinical asthma remission
Sponsor: Mahidol University
Recruiting – verified August 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Eosinophilic Esophagitis
Interventions: Drug: Budesonide effervescent 0.5mg tablet twice daily; Drug: Budesonide effervescent 1mg tablet twice daily; Drug: Placebo effervescent tablet twice daily
Sponsor: Dr. Falk Pharma GmbH
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Asthma remission common among boys
Healio The study included 248 children aged 7 to 8 years in northern Sweden identified as having asthma. Participants were re-evaluated annually until aged 19 years (205 remained). Lung function, bronchial challenge testing and skin prick tests were performed … Breathing Easier While Growing Up |
View full post on asthma – Google News
TopNews Arab Emirates |
Allergic asthma remission with three year treatment: study
Outcome Magazine (blog) Asthma Airways Though there is no known cure for dust mite induced allergies or asthma, long-term relief may be within reach with a three year regiment of immunotherapy (allergy shots), according to a new study, published in the October issue of Annals … Relief from Allergic Asthma in Just Three Years Dust mite allergy treatment shortened by new research (Video) Now, there's long-term control of allergic asthma |
View full post on asthma – Google News
Aggressive allergy treatment for asthma remission
6minutes Targeting allergic conditions in children with “aggressive treatment” could prevent them from still having asthma by middle age, a new study suggests. Using data gathered over 40 years, researchers in Victoria found … |
View full post on asthma – Google News